Structure based drug design

Access to the complete human genome sequence as well as to the complete sequences of pathogenic organisms provides information that can result in an avalanche of therapeutic targets.structure-based design is one of the first techniques to be used in drug design.structure based design refers specifically to finding and complementing the 3D structure (binding and/or active sites) of a target molecule such as a receptor protein.